Clinical Practice

Use the tool below to view all available Global Oncology Academy Series

Shared Decision-Making in Squamous Cell Carcinoma of the Anal Canal
Shared Decision-Making in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®
Shared Decision-Making in Squamous Cell Carcinoma of the Anal Canal
- Brian P. McDonough, MD, FAAFP
- Richard Kim, MD
The Clinical Consequences of Delayed Colorectal Cancer Screening
The Clinical Consequences of Delayed Colorectal Cancer Screening
Clinician's Roundtable
The Clinical Consequences of Delayed Colorectal Cancer Screening
- Peter Buch, MD, FACG, AGAF, FACP
- Christopher Cann, MD
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Project Oncology®
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Protecting Heart Health in Metastatic Breast Cancer
Protecting Heart Health in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Protecting Heart Health in Metastatic Breast Cancer
- Ryan Quigley
- Gregory Vidal, MD, PhD
Embedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
Embedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
Clinician's Roundtable
Embedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
Personalized Risk Communication and Its Effect on CRC Screening Choice
Personalized Risk Communication and Its Effect on CRC Screening Choice
Clinician's Roundtable
Personalized Risk Communication and Its Effect on CRC Screening Choice
Evolving Approaches to Early-Onset CRC Detection
Evolving Approaches to Early-Onset CRC Detection
On the Frontlines of Colorectal Cancer
Evolving Approaches to Early-Onset CRC Detection
- Peter Buch, MD, FACG, AGAF, FACP
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
- Charles Turck, PharmD, BCPS, BCCCP
- Marwan G. Fakih, MD
Comparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
Comparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
AudioAbstracts
Comparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
- Ryan Quigley
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
AudioAbstracts
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
- Ryan Quigley
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
On the Frontlines of AML/ALL
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
- Ryan Quigley
- Amanda Winters, MD, PhD
Understanding the Growing Burden of Early-Onset CRC
Understanding the Growing Burden of Early-Onset CRC
On the Frontlines of Colorectal Cancer
Understanding the Growing Burden of Early-Onset CRC
- Ryan Quigley
- Christopher Cann, MD
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CE
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
0.25 credits
- Benjamin Levy, MD
0.25 credits
Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
- Abirami Sivapiragasam
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
On the Frontlines of AML/ALL
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
- Charles Turck, PharmD, BCPS, BCCCP
- Lena Winestone, MD, MSHP
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Project Oncology®
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
- Geoffrey Oxnard, MD

Clinical Practice

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

Clinical Practice

Popular

Title

Share on ReachMD

Welcome to the newGlobal Oncology Academy website.

Welcome to the new
Global Oncology Academy website.